Active clinical trials for "Cocaine-Related Disorders"

The purpose of this study is to assess the efficacy and safety of reserpine for the treatment of cocaine dependence.

Cocaine has been cited as the primary drug threat in the United States. The purpose of this study is to determine if cocaethylene, used as a prototype drug, is a safe and effective treatment for cocaine dependence.

The purpose of this study is to assess tiagabine for the treatment of cocaine dependence.

To determine if acute assessments of profasi and factrel affect plasma cocaine levels and cocaine-induced behavioral changes in men.

The purpose of this study is to compare the efficacy of carbamazepine in treatment of cocaine-dependence in patients with affective disorders.

The purpose of this study is to confirm whether a blood level ""ceiling"" exists on desipramine effect in cocaine abuse.

The purpose of this study is to evaluate high and low dose mazindol for cocaine abuse.

The purpose of this study is to evaluate glutaminergic agents for cocaine abuse.

The purpose of this study is to determine the effects of nefazedone on cocaine self-administration in depressed and non-depressed female cocaine users.

The purpose of this study is to evaluate alterations in the serotonergic system in cocaine addicts and attempt to dissociate changes secondary to cocaine use from those associated with premorbid characteristics.